TIMOTHY GOBRECHT: Open Payments
NPI 1578964821 · RIDLEY PARK, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,441 in 206 payments from 30 companies in 2025. Trend: 2023 $2,285 · 2024 $3,017 · 2025 $3,441
Food & beverage: $3,442
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 35 | $552 |
| PFIZER INC. | 26 | $318 |
| AstraZeneca Pharmaceuticals LP | 15 | $300 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 23 | $296 |
| Novo Nordisk Inc | 15 | $219 |
| GlaxoSmithKline, LLC. | 10 | $205 |
| Lilly USA, LLC | 7 | $171 |
| Exact Sciences Corporation | 8 | $168 |
| Kowa Pharmaceuticals America, Inc. | 13 | $162 |
| Otsuka America Pharmaceutical, Inc. | 8 | $143 |
Products named: VRAYLAR, XIFAXAN, NURTEC ODT, REXULTI, Cologuard Collection Kit, ZORYVE, JARDIANCE, FARXIGA.
Industry payments across PA — which companies pay providers there.
